Scaled Biolabs accelerates discovery and development of cell therapies, leveraging microfluidics, automation and machine learning.
Industries BiotechnologyHeadquarters Regions San Francisco Bay Area, West Coast, Western US Founded Date 2016 Founders Brendan Griffen, Drew Titmarsh, Justin Cooper-White Operating Status Active Last Funding Type Seed
Company Type For Profit
Contact Email mail@scaledbiolabs.com Phone Number +114156551868
Scaled Biolabs is pioneering a Cell Therapy Discovery Engine, working at the frontier of microfluidics, automation, and machine learning to develop best-in-class cell-based medicines. This engine enables leading biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes, providing an
unprecedented window into cell-driven biology. This enables the development of novel and optimal cell-based products and processes, simplifying manufacturing, reducing time to market, and improving clinical outcomes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson’s disease.